Concord Medical Company Leadership
CCM Stock | USD 5.58 0.08 1.41% |
Concord Medical employs about 595 people. The company is managed by 13 executives with a total tenure of roughly 94 years, averaging almost 7.0 years of service per executive, having 45.77 employees per reported executive. Analysis of Concord Medical's management performance can provide insight into the firm performance.
Jianyu Yang Chairman Chairman, CEO, Chairman of Compensation Committee and Member of Investment Committee |
Zheng Cheng President President, Director and Member of Investment Committee |
Concord Medical Management Team Effectiveness
The company has Return on Asset of (0.0521) % which means that on every $100 spent on assets, it lost $0.0521. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3876) %, meaning that it generated no profit with money invested by stockholders. Concord Medical's management efficiency ratios could be used to measure how well Concord Medical manages its routine affairs as well as how well it operates its assets and liabilities.Concord Medical Workforce Comparison
Concord Medical Services is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 56,986. Concord Medical claims roughly 595 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Net Profit Margin of (0.8) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (2.02) %, which entails that for every $100 of revenue, it lost $2.02. Concord Medical Services Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Concord Medical Services Price Series Summation is a cross summation of Concord Medical price series and its benchmark/peer.
Concord Medical Notable Stakeholders
A Concord Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Concord Medical often face trade-offs trying to please all of them. Concord Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Concord Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jianyu Yang | Chairman, CEO, Chairman of Compensation Committee and Member of Investment Committee | Profile | |
Zheng Cheng | President, Director and Member of Investment Committee | Profile | |
Yaw Yap | CFO and Member of Investment Committee | Profile | |
Fu Xiao | Chief Operating Officer | Profile | |
Weibo Yin | Independent Director and Member of Audit Committee | Profile | |
Ting Lee | Independent Non-Executive Director | Profile | |
Xun Liu | Financial Controller | Profile | |
Matthew Callister | Chief Medical Officer | Profile | |
Boxun Zhang | Independent Director | Profile | |
Yue Yu | Director | Profile | |
Qing Pan | Director | Profile | |
Wei Jiang | Chief Officer | Profile | |
Liping Zhang | Independent Director | Profile |
About Concord Medical Management Performance
The success or failure of an entity such as Concord Medical Services often depends on how effective the management is. Concord Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Concord management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Concord management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the Peoples Republic of China. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the Peoples Republic of China. Concord Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 972 people.
Concord Medical Workforce Analysis
Traditionally, organizations such as Concord Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Concord Medical within its industry.Concord Medical Manpower Efficiency
Return on Concord Medical Manpower
Revenue Per Employee | 645.3K | |
Revenue Per Executive | 29.5M | |
Net Loss Per Employee | 1.1M | |
Net Loss Per Executive | 50.2M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Healthcare space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.